Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 381 record(s)

Req # A-2023-000477

Adverse Drug Reactions (ADRs). Report numbers: E2B_06307970, 001038412, E2B_06307631, 001037612, 001038278, 001038993, E2B_06274285, 001040196, E2B_06332889, E2B_06286966.

Organization: Health Canada

148 page(s)
September 2023

Req # A-2023-000478

Adverse Drug Reactions (ADRs). Report numbers: E2B_06333161, E2B_06283221, E2B_06288346, 001035117, E2B_06310891, E2B_06310879, E2B_06297285, 001037269, E2B_06269245, 001036556.

Organization: Health Canada

171 page(s)
September 2023

Req # A-2023-000484

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-102152-249.

Organization: Health Canada

5 page(s)
September 2023

Req # A-2023-000529

Adverse Drug Reaction (ADR). Report number: E2B_02891245.

Organization: Health Canada

28 page(s)
September 2023

Req # A-2023-000546

Adverse Drug Reaction (ADR) for PMS-AZITHROMYCIN. Report number: E2B_06272934.

Organization: Health Canada

10 page(s)
September 2023

Req # A-2023-000548

Adverse Drug Reaction (ADR). Report number: E2B_06076856.

Organization: Health Canada

69 page(s)
September 2023

Req # A-2023-000585

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-100477-111.

Organization: Health Canada

9 page(s)
September 2023

Req # A-2023-000641

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-105497-388.

Organization: Health Canada

9 page(s)
September 2023

Req # A-2023-000652

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107286-706.

Organization: Health Canada

12 page(s)
September 2023

Req # A-2023-000653

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-103403-403.

Organization: Health Canada

14 page(s)
September 2023
Date modified: